In8bio Inc (INAB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.86M
Last updated: Nov 17, 2026 at 11:04 AM ET
In8bio Inc (INAB) Earnings: Report Dates and Results
In8bio (INAB) is expected to report earnings on Mar 10, 2027. In the quarter ended Sep 30, 2026, In8bio reported EPS of -$0.24, above the -$0.57 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
INAB has an expected report date of Mar 10, 2027.
Earnings History
Of the 23 quarters below that had an estimate, INAB beat 11, missed 9 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2026, when EPS landed 62.32% above the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.24 | -$0.57 | -$0.57 - -$0.22 | +57.89% | Beat | N/A | 3 | 1 up, 0 down | Nov 5, 2026 |
| Jun 30, 2026 | -$0.25 | -$0.61 | -$0.61 - -$0.24 | +59.02% | Beat | N/A | 3 | 0 up, 0 down | Aug 6, 2026 |
| Mar 31, 2026 | -$0.26 | -$0.69 | -$0.79 - -$0.59 | +62.32% | Beat | N/A | 2 | 0 up, 0 down | May 7, 2026 |
| Dec 31, 2025 | -$0.45 | -$0.48 | -$0.77 - -$0.18 | +5.26% | Beat | N/A | 2 | 0 up, 0 down | Mar 12, 2026 |
| Sep 30, 2025 | -$0.85 | -$1.25 | -$1.28 - -$1.21 | +32.00% | Beat | N/A | 2 | 2 up, 0 down | Nov 6, 2025 |
| Jun 30, 2025 | -$1.24 | -$1.50 | -$2.10 - -$1.50 | +17.33% | Beat | N/A | 3 | 1 up, 0 down | Aug 7, 2025 |
| Mar 31, 2025 | -$2.10 | -$2.00 | -$2.10 - -$1.80 | -5.00% | Miss | N/A | 3 | 1 up, 0 down | May 7, 2025 |
| Dec 31, 2024 | -$0.08 | -$0.07 | -$0.10 - -$0.07 | -14.29% | Miss | N/A | 4 | 2 up, 0 down | Mar 13, 2025 |
| Sep 30, 2024 | -$4.50 | -$4.72 | -$5.41 - -$4.20 | +4.66% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | -$5.70 | -$5.04 | -$6.31 - -$4.50 | -13.10% | Miss | N/A | 5 | 0 up, 0 down | Aug 8, 2024 |
| Mar 31, 2024 | -$6.00 | -$5.18 | -$6.01 - -$4.50 | -15.83% | Miss | N/A | 4 | 0 up, 0 down | May 9, 2024 |
| Dec 31, 2023 | -$0.21 | -$0.15 | -$0.17 - -$0.13 | -40.00% | Miss | N/A | 3 | 0 up, 0 down | Mar 14, 2024 |
| Sep 30, 2023 | -$6.90 | -$7.35 | -$7.51 - -$7.21 | +6.12% | Beat | N/A | 2 | 0 up, 0 down | Nov 9, 2023 |
| Jun 30, 2023 | -$8.10 | -$8.10 | -$8.41 - -$7.51 | 0.00% | In line | N/A | 3 | 0 up, 0 down | Aug 10, 2023 |
| Mar 31, 2023 | -$9.00 | -$9.60 | -$9.91 - -$8.11 | +6.25% | Beat | N/A | 3 | 2 up, 0 down | May 12, 2023 |
| Dec 31, 2022 | -$0.37 | -$0.32 | -$0.35 - -$0.28 | -15.63% | Miss | N/A | 3 | 0 up, 0 down | Mar 30, 2023 |
| Sep 30, 2022 | -$10.20 | -$8.10 | -$10.21 - -$7.81 | -25.93% | Miss | N/A | 3 | 0 up, 0 down | Nov 10, 2022 |
| Jun 30, 2022 | -$11.40 | -$8.70 | -$9.91 - -$7.51 | -31.03% | Miss | N/A | 2 | 0 up, 0 down | Aug 12, 2022 |
| Mar 31, 2022 | -$9.90 | -$9.90 | -$10.21 - -$9.61 | 0.00% | In line | N/A | 2 | 0 up, 0 down | May 12, 2022 |
| Dec 31, 2021 | -$0.21 | -$0.26 | -$0.32 - -$0.21 | +19.23% | Beat | N/A | 2 | 0 up, 0 down | Mar 17, 2022 |
| Sep 30, 2021 | -$7.50 | -$8.25 | -$15.32 - -$6.01 | +9.09% | Beat | N/A | 2 | 0 up, 0 down | Nov 10, 2021 |
| Jun 30, 2021 | -$0.55 | -$0.40 | N/A | -37.50% | Miss | N/A | N/A | N/A | Jul 30, 2021 |
| Mar 31, 2021 | -$0.82 | -$0.82 | N/A | 0.00% | In line | N/A | N/A | N/A | Jun 2, 2021 |
| Dec 31, 2020 | -$0.82 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 |
| Sep 30, 2020 | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 5, 2020 |
| Jun 30, 2020 | -$0.69 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2020 |
| Dec 31, 2019 | -$0.59 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2020 |
| Sep 30, 2019 | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Dec 31, 2019 |
| Jun 30, 2019 | -$0.48 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2019 |
| Mar 31, 2019 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2019 |
| Dec 31, 2018 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2019 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$4.64, after -$16.28 the year before. It was -$0.16 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$4.64 | N/A |
| Dec 31, 2024 | -$16.28 | N/A |
| Dec 31, 2023 | -$24.21 | N/A |
| Dec 31, 2022 | -$31.87 | N/A |
| Dec 31, 2021 | -$9.08 | N/A |
| Dec 31, 2020 | -$1.81 | N/A |
| Dec 31, 2019 | -$1.71 | N/A |
| Dec 31, 2018 | -$0.16 | N/A |
Frequently Asked Questions About INAB
When is In8bio's next earnings date?
In8bio's next earnings report is expected for Mar 10, 2027.
Did INAB beat earnings estimates last quarter?
Yes. In8bio reported EPS of -$0.24 for the quarter ended Sep 30, 2026, above the -$0.57 estimate, a 57.89% surprise.
What EPS do analysts expect from INAB next quarter?
The consensus EPS estimate for In8bio for the quarter ending Dec 31, 2026 is -$0.36 from 5 analysts, with estimates from -$0.64 to -$0.18.
How often does INAB beat earnings estimates?
In8bio beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +26.82%.
INAB pages: Overview, Earnings, Forecast, Financials, Competitors